Skip to main content
Veterinary Medicines

Laurabolin 25 mg/ml Oplossing voor injectie

Authorised
  • Nandrolone laurate

Product identification

Medicine name:
Laurabolin 25 mg/ml Oplossing voor injectie
Laurabolin 25 mg/ml Solution injectable
Laurabolin 25 mg/ml Injektionslösung
Active substance:
  • Nandrolone laurate
Target species:
  • Dog
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Nandrolone laurate
    25.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Dog
  • Subcutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA14AB01
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Package description:
  • Laurabolin Vial with 10 ml Solution for injection
  • Laurabolin Vial with 5 ml Solution for injection

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International GmbH
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V011891
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 8/12/2023
French (PDF)
Published on: 8/12/2023

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 8/12/2023
French (PDF)
Published on: 8/12/2023
German (PDF)
Published on: 8/12/2023

Labelling

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 21/12/2023
French (PDF)
Published on: 21/12/2023
German (PDF)
Published on: 21/12/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."